Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
Kenya is facing a critical vaccine shortage, with stock levels expected to run out by June 2025, putting millions of children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback